Clinical Trial Update: A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant apalutamide with androgen deprivation therapy after radical prostatectomy in men with non-metastatic, high-risk prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2024-11-19